BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3937942)

  • 1. [Chemotherapy of patients with chronic destructive pulmonary tuberculosis in cases of mycobacterial resistance to rifampicin and isoniazid].
    Bialik IB; Klimenko MT
    Klin Med (Mosk); 1985 Dec; 63(12):42-7. PubMed ID: 3937942
    [No Abstract]   [Full Text] [Related]  

  • 2. [The microbiological diagnosis of tuberculosis in areas under strict radiation control].
    Golyshevskaia VI; Cheshek VG; Shevchenko NI
    Probl Tuberk; 1993; (6):30-2. PubMed ID: 8290527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical course and chemotherapy of hyperchronic destructive pulmonary tuberculosis].
    Mamolat AS; Bialik IB; Khutorskaia VD
    Probl Tuberk; 1985; (10):24-8. PubMed ID: 3934660
    [No Abstract]   [Full Text] [Related]  

  • 4. [Virulence of rifampicin-resistent Mycobacterium tuberculosis].
    Klimenko MT
    Probl Tuberk; 1978 Jun; (6):73-7. PubMed ID: 97662
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bacteriologic negation and anatomic development in pulmonary specimens after rifampicin treatment of less than 10 months (10 cases)].
    Constans P; Parrot R; Coury C
    Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):511-8. PubMed ID: 4994883
    [No Abstract]   [Full Text] [Related]  

  • 6. Bacteriologic basis of short-course chemotherapy for tuberculosis.
    Grosset J
    Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
    [No Abstract]   [Full Text] [Related]  

  • 7. [Rifampicin in the treatment of patients with chronic destructive tuberculosis complicated by drug intolerance and Mycobacterium drug resistance].
    Adamovich VN; Kolomytseva OS; Gur'ian IE
    Vrach Delo; 1975 Jan; (1):95-9. PubMed ID: 806177
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis].
    Mkrtchian SV; Ushkin VV
    Antibiotiki; 1971 May; 16(5):472-7. PubMed ID: 5002224
    [No Abstract]   [Full Text] [Related]  

  • 9. [Efficiency of chemotherapy of destructive pulmonary tuberculosis, based on the results of rapid detection of drug sensitivity to isoniazid and rifampicin with the "TB-Biochip" test system].
    Kuz'min AV; Vasil'eva IA; Chernousova LN
    Probl Tuberk Bolezn Legk; 2006; (8):17-23. PubMed ID: 17002052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of rifampicin on the L transformation of a mycobacterial population in patients with destructive pulmonary tuberculosis].
    Karachunskiĭ MA; Dorozhkova IR; Chukanov VI; Balta IuE; Kiazimova LM
    Probl Tuberk; 1986; (9):31-4. PubMed ID: 3097632
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical significance of Mycobacterium tuberculosis polydrug resistance in chronic destructive forms of pulmonary tuberculosis].
    Bialik IB; Klimenko MT
    Probl Tuberk; 1980 Oct; (10):68-70. PubMed ID: 6776517
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rifampicin resistence and virulence of M. tuberculosis for guinea pigs].
    Schröder KH; Koperska C
    Zentralbl Bakteriol Orig A; 1972 Jan; 219(1):112-3. PubMed ID: 4402403
    [No Abstract]   [Full Text] [Related]  

  • 13. [L-transformation of the mycobacterial population in the process of treating patients with newly detected destructive pulmonary tuberculosis].
    Khomenko AG; Karachunskiĭ MA; Dorozhkova IR; Chukanov VI; Balta IuE
    Probl Tuberk; 1980 Feb; (2):18-23. PubMed ID: 6769110
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effectiveness of the standard mode of chemotherapy for newly-diagnosed patients with destructive pulmonary tuberculosis with bacterial isolation].
    Mishin VIu; Chukanov VI; Vylegzhanin SV
    Probl Tuberk; 2001; (7):13-8. PubMed ID: 11763553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of primary drug resistance in pulmonary tuberculosis in west Malaysia 1984-1987.
    Jalleh RD; Kuppusamy I; Soshila R; Aziah AM; Faridza MY
    Med J Malaysia; 1993 Jun; 48(2):113-6. PubMed ID: 8350784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological characteristics of rifampicin-resistant Mycobacterium tuberculosis].
    Klimenko MT
    Antibiotiki; 1984 Mar; 29(3):185-8. PubMed ID: 6428304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy of chronic destructive tuberculosis of the lungs and some disputable drugs.
    Schmelev NA
    Scand J Respir Dis Suppl; 1968; 65():147-50. PubMed ID: 4978458
    [No Abstract]   [Full Text] [Related]  

  • 18. [Usefulness of rifampicin for pulmonary resection of drug-resistant pulmonary tuberculosis--report of the 13th series study. C].
    Kekkaku; 1973 Jan; 48(1):29-33. PubMed ID: 4632268
    [No Abstract]   [Full Text] [Related]  

  • 19. [Virulence of polyresistant strains of Mycobacterium tuberculosis].
    Drabkina RO; Klimenko MT
    Probl Tuberk; 1978 Nov; (11):70-5. PubMed ID: 103091
    [No Abstract]   [Full Text] [Related]  

  • 20. [Rifamicin in the studies of the Scuola Tisiologica in Naples].
    Nitti V
    Arch Tisiol Mal Appar Respir; 1968 Apr; 23(4):271-92. PubMed ID: 4981409
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.